These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10694102)

  • 41. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
    Firsova VA; Poluĕktova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Advances in the study of drugs for the treatment of multi-drug resistant tuberculosis].
    Tang SJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):567-9. PubMed ID: 17074274
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tuberculosis becomes a global menace. Constantly more multiresistance].
    Einecke D
    MMW Fortschr Med; 2007 Apr; 149(16):13-4. PubMed ID: 17953258
    [No Abstract]   [Full Text] [Related]  

  • 44. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 45. Papulonecrotic tuberculid in a human immunodeficiency virus type-1 patient with multidrug-resistant tuberculosis.
    Fernandes C; Maltez F; Lourenço S; Morgado A; Proença R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):369-70. PubMed ID: 15096159
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypothyroidism in a patient receiving treatment for multidrug-resistant tuberculosis.
    Soumakis SA; Berg D; Harris HW
    Clin Infect Dis; 1998 Oct; 27(4):910-1. PubMed ID: 9798062
    [No Abstract]   [Full Text] [Related]  

  • 47. European expansion. Outwitting TB on the E.U.'s eastern frontier.
    Enserink M
    Science; 2004 Apr; 304(5668):199. PubMed ID: 15073353
    [No Abstract]   [Full Text] [Related]  

  • 48. The clinical management of drug-resistant tuberculosis.
    Furin J
    Curr Opin Pulm Med; 2007 May; 13(3):212-7. PubMed ID: 17414129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.
    Lee HW; Kim DW; Park JH; Kim SD; Lim MS; Phapale PB; Kim EH; Park SK; Yoon YR
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MDR-TB: a challenge for the 21st century.
    Petryszyn K; LeLacheur S
    JAAPA; 2002 Apr; 15(4):51-2, 57-8, 63-4 passim; quiz 65-6. PubMed ID: 12012587
    [No Abstract]   [Full Text] [Related]  

  • 51. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
    Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa.
    Wilton P; Smith RD; Coast J; Millar M; Karcher A
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1137-42. PubMed ID: 11769772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
    Shin SS; Hyson AM; Castañeda C; Sánchez E; Alcántara F; Mitnick CD; Fawzi MC; Bayona J; Farmer PE; Kim JY; Furin JJ
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):347-53. PubMed ID: 12729340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
    Vanino E; Tadolini M; Attard L; Cascavilla A; Pea F; Viale P
    Int J Tuberc Lung Dis; 2019 Sep; 23(9):1042. PubMed ID: 31615614
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug resistance in pulmonary tuberculosis in Istanbul.
    Kilicaslan Z; Albal H; Kiyan E; Aydemir N; Seber E
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):763-4. PubMed ID: 12415480
    [No Abstract]   [Full Text] [Related]  

  • 57. [Levels of free and acetylized PAS in the blood after the administration ALPAS].
    Kostić M; Krajovan R
    Tuberkuloza; 1966; 18(5):469-76. PubMed ID: 16296053
    [No Abstract]   [Full Text] [Related]  

  • 58. Can a nine-month regimen be used to treat isoniazid resistant tuberculosis diagnosed after standard treatment is started?
    Ormerod LP; Horsfield N; Green RM
    J Infect; 2001 Jan; 42(1):1-3. PubMed ID: 11243745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should isoniazid and clofazimine be used to treat multidrug-resistant tuberculosis?
    Seung KJ
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):231-2; author reply 232. PubMed ID: 15732749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.